Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kay L Double

Showing results (11-20 of 56) with videos related to

Pageof 6
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 2020
Meta-Analysis of Copper and Iron in Parkinson's Disease Brain and BiofluidsSian Genoud, Alistair M Senior, Dominic J Hare, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 16, 2013
Variability in neuronal expression of dopamine receptors and transporters in the substantia nigraStefanie Reyes, Veronica Cottam, Deniz Kirik, et al.
Clinical Science (London, England : 1979)|March 10, 2016
Copper dyshomoeostasis in Parkinson's disease: implications for pathogenesis and indications for novel therapeuticsKatherine M Davies, Julian F B Mercer, Nicholas Chen, et al.
Plos One|October 2, 2024
The background and experience of neuroscience teachers in Australian universities: A cross-sectional surveyGabrielle Todd, Fabian Kreilaus, Amy S Lonergan, et al.
Experimental Neurology|October 18, 2011
L-DOPA is incorporated into brain proteins of patients treated for Parkinson's disease, inducing toxicity in human neuroblastoma cells in vitroSandra W Chan, Rachael A Dunlop, Anthony Rowe, et al.
Journal of Neurochemistry|September 14, 2010
Effect of age on proliferation-regulating factors in human adult neurogenic regionsEryn L Werry, Shilpa Enjeti, Glenda M Halliday, et al.
Plos One|March 1, 2021
Measurement of the adult human midbrain with transcranial ultrasoundKarl Aoun, Kay L Double, Verity Pearson-Dennett, et al.
Angewandte Chemie (International Ed. in English)|March 8, 2020
Superoxide Dismutase 1 in Health and Disease: How a Frontline Antioxidant Becomes NeurotoxicBenjamin G Trist, James B Hilton, Dominic J Hare, et al.
Aging Cell|August 3, 2017
Evidence for reduced neurogenesis in the aging human hippocampus despite stable stem cell markersKathryn J Mathews, Katherine M Allen, Danny Boerrigter, et al.
Journal of Alzheimer'S Disease : JAD|September 23, 2010
Low serum progranulin predicts the presence of mutations: a prospective studyEmma C Schofield, Glenda M Halliday, John Kwok, et al.
Pageof 6

Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 2020
Meta-Analysis of Copper and Iron in Parkinson's Disease Brain and BiofluidsSian Genoud, Alistair M Senior, Dominic J Hare, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 16, 2013
Variability in neuronal expression of dopamine receptors and transporters in the substantia nigraStefanie Reyes, Veronica Cottam, Deniz Kirik, et al.
Clinical Science (London, England : 1979)|March 10, 2016
Copper dyshomoeostasis in Parkinson's disease: implications for pathogenesis and indications for novel therapeuticsKatherine M Davies, Julian F B Mercer, Nicholas Chen, et al.
Plos One|October 2, 2024
The background and experience of neuroscience teachers in Australian universities: A cross-sectional surveyGabrielle Todd, Fabian Kreilaus, Amy S Lonergan, et al.
Experimental Neurology|October 18, 2011
L-DOPA is incorporated into brain proteins of patients treated for Parkinson's disease, inducing toxicity in human neuroblastoma cells in vitroSandra W Chan, Rachael A Dunlop, Anthony Rowe, et al.
Journal of Neurochemistry|September 14, 2010
Effect of age on proliferation-regulating factors in human adult neurogenic regionsEryn L Werry, Shilpa Enjeti, Glenda M Halliday, et al.
Plos One|March 1, 2021
Measurement of the adult human midbrain with transcranial ultrasoundKarl Aoun, Kay L Double, Verity Pearson-Dennett, et al.
Angewandte Chemie (International Ed. in English)|March 8, 2020
Superoxide Dismutase 1 in Health and Disease: How a Frontline Antioxidant Becomes NeurotoxicBenjamin G Trist, James B Hilton, Dominic J Hare, et al.
Aging Cell|August 3, 2017
Evidence for reduced neurogenesis in the aging human hippocampus despite stable stem cell markersKathryn J Mathews, Katherine M Allen, Danny Boerrigter, et al.
Journal of Alzheimer'S Disease : JAD|September 23, 2010
Low serum progranulin predicts the presence of mutations: a prospective studyEmma C Schofield, Glenda M Halliday, John Kwok, et al.
Pageof 6